Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 255 Rectal Neoplasms 155 Colonic Neoplasms 128 Stomach Neoplasms 100 Pancreatic Neoplasms 94 Breast Neoplasms 77 Esophageal Neoplasms 76 Neoplasm Metastasis 58 Squamous Cell Carcinoma of Head and Neck 56 Head and Neck Neoplasms 56 Neoplasms 43 Adenocarcinoma Of Esophagus 37 Esophageal Squamous Cell Carcinoma 27 Adenocarcinoma 25 Unspecified Adult Solid Tumor, Protocol Specific 15 Carcinoma, Hepatocellular 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Anus Neoplasms 12 Keratosis, Actinic 11 Gastrointestinal Neoplasms 11 Biliary Tract Neoplasms 11 Gallbladder Neoplasms 10 Carcinoma, Squamous Cell 10 Urinary Bladder Neoplasms 9 Nasopharyngeal Carcinoma 9 Liver Neoplasms 9 Cholangiocarcinoma 9 Carcinoma 9 Bile Duct Neoplasms 9 Recurrence 8

Interventions

Nivolumab 4 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Various Advanced Cancer × Fluorouracil × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡